ISLAND PHARMACEUTICALS LIMITED - Announcements

19.2%

43.5¢

Market Cap $110.3M

Healthcare Biotechnology

Island Pharmaceuticals Ltd is an Australia-based drug repurposing company. The Company is... Island Pharmaceuticals Ltd is an Australia-based drug repurposing company. The Company is focused on areas of unmet need for antiviral therapeutics to address infectious diseases. Its lead asset is ISLA-101, a drug with a safety profile being repurposed for the prevention and treatment of dengue2 fever and other mosquito (or vector) borne diseases. ISLA-101 has been shown to have activity against all four strains of dengue virus as well as other flaviviruses such as Zika virus, West Nile virus, and Yellow Fever virus, as well as Chikungunya virus. While ISLA-101 is an oral formulation, the Company is also considering alternative formulations, including a long-acting oral formulation and intravenous formulations for severe dengue infections. The Company operates a single segment, being research and development activities principally in the geographic regions of Australia and the United States. Its subsidiary is Isla Pharmaceuticals Inc.More

ASX:AFP

Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals (ASX:AFP). With biotech stocks broadly having a strong run in 2025, and with more of the year ahead, investors are still looking for stocks in the sector with room to run. Latest:...

Announcements

Filter Results

All Price Sensitive Only

ILA	FDA Meeting request granted	PRICE SENSITIVE	19/09/25	126KB	Share
ILA	Investor webinar		18/09/25	122.36KB	Share
ILA	Investor presentation - Galidesivir update		17/09/25	1.61MB	Share
ILA	Cleansing Notice		09/09/25	192.13KB	Share
ILA	Application for quotation of securities - ILA		09/09/25	15.54KB	Share
ILA	Letter to Shareholders, Notice of AGM & Proxy Form		05/09/25	515.45KB	Share
ILA	FDA meeting request lodged for Galidesivir	PRICE SENSITIVE	01/09/25	138.45KB	Share
ILA	Annual Report to shareholders (incl auditor independence)		29/08/25	1.96MB	Share
ILA	Appendix 4G and Corporate Governance Statement		29/08/25	555.52KB	Share
ILA	Annual Report to shareholders		29/08/25	1.89MB	Share
ILA	Preliminary Final Report	PRICE SENSITIVE	29/08/25	219.79KB	Share
ILA	Change in substantial holding		15/08/25	125.66KB	Share
ILA	Date of AGM & Closing Date for Director Nominations		14/08/25	269.6KB	Share
ILA	Presentation to the Third Annual Dengue Endgame Summit		14/08/25	910.2KB	Share
ILA	Options exercise from existing substantial shareholder	PRICE SENSITIVE	11/08/25	132KB	Share
ILA	Cleansing Notice		11/08/25	215.07KB	Share
ILA	Application for quotation of securities - ILA		11/08/25	15.64KB	Share
ILA	Completion of Galidesivir transaction	PRICE SENSITIVE	31/07/25	139.13KB	Share
ILA	Investor Presentation and investor roadshow		28/07/25	1.54MB	Share
ILA	Change of Director's Interest Notice - JC		25/07/25	4.22KB	Share
ILA	Quarterly Appendix 4C and Activities Report	PRICE SENSITIVE	24/07/25	322.82KB	Share
ILA	Change in substantial holding		17/07/25	916.52KB	Share
ILA	Options exercise from existing substantial shareholder	PRICE SENSITIVE	17/07/25	203.8KB	Share
ILA	Cleansing Notice		16/07/25	127.73KB	Share
ILA	Application for quotation of securities - ILA		16/07/25	18.19KB	Share
ILA	Investor presentation		09/07/25	836.38KB	Share
ILA	Portfolio expansion achieved with acquisition of Galidesivir	PRICE SENSITIVE	09/07/25	176.75KB	Share
ILA	Trading Halt	PRICE SENSITIVE	07/07/25	327.78KB	Share
ILA	Notification of cessation of securities - ILA		04/07/25	13KB	Share
ILA	Cancel - Notification of cessation of securities - ILA		04/07/25	12.63KB	Share
ILA	Initial Director's Interest Notice		03/07/25	237.76KB	Share
ILA	Notification of cessation of securities - ILA		03/07/25	12.95KB	Share
ILA	Final Director's Interest Notice		03/07/25	268.22KB	Share
ILA	Appointment of Jason Carroll as Non-Executive Chairman		02/07/25	137.5KB	Share
ILA	Webinar presentation		17/06/25	1.53MB	Share
ILA	Successful Phase 2 clinical trial of ISLA-101	PRICE SENSITIVE	12/06/25	185.05KB	Share
ILA	Trading Halt	PRICE SENSITIVE	10/06/25	291.09KB	Share
ILA	Cleansing Notice		04/06/25	230.14KB	Share
ILA	Application for quotation of securities - ILA		04/06/25	15.66KB	Share
ILA	Change in substantial holding		03/06/25	853.1KB	Share
ILA	Change in substantial holding		02/06/25	270.65KB	Share
ILA	Change in substantial holding		29/05/25	264.18KB	Share
ILA	Cleansing Notice		29/05/25	133.9KB	Share
ILA	Application for quotation of securities - ILA		29/05/25	15.67KB	Share
ILA	Proposed issue of securities - ILA		21/05/25	14.86KB	Share
ILA	Proposed issue of securities - ILA		21/05/25	15.72KB	Share
ILA	Proposed issue of securities - ILA		21/05/25	15.59KB	Share
ILA	Island completes $3.6 million placement	PRICE SENSITIVE	21/05/25	152.6KB	Share
ILA	Trading Halt	PRICE SENSITIVE	19/05/25	342.25KB	Share
ILA	Investor Presentation		08/05/25	1.55MB	Share
ILA	Quarterly Activities & Cashflow Report	PRICE SENSITIVE	30/04/25	293.98KB	Share
ILA	Phase 2a/b clinical trial update	PRICE SENSITIVE	23/04/25	147.37KB	Share
ILA	Notification of cessation of securities - ILA		14/04/25	12.83KB	Share
ILA	Change in substantial holding		26/03/25	154.55KB	Share
ILA	Ceasing to be a substantial holder		25/03/25	122.32KB	Share
ILA	Change in substantial holding		25/03/25	265.65KB	Share
ILA	Change in substantial holding		24/03/25	267.14KB	Share
ILA	Spark Plus Healthcare Conference Investor Presentation		24/03/25	1.47MB	Share
ILA	Change in substantial holding		21/03/25	820KB	Share
ILA	Total of $2.72m raised from ILAO options		19/03/25	148.5KB	Share
ILA	Notification of cessation of securities - ILA		19/03/25	223.09KB	Share
ILA	Change of Director's Interest Notice - PL		19/03/25	139.75KB	Share
ILA	Application for quotation of securities - ILA		19/03/25	337KB	Share
ILA	Application for quotation of securities - ILA		12/03/25	336.88KB	Share
ILA	Change of Director's Interest Notice - DF		05/03/25	145.29KB	Share
ILA	Application for quotation of securities - ILA		05/03/25	15.57KB	Share
ILA	Cleansing Notice		05/03/25	130.25KB	Share
ILA	Application for quotation of securities - ILA		05/03/25	16.44KB	Share
ILA	Application for quotation of securities - ILA		05/03/25	16.45KB	Share
ILA	Appendix 4D & Half-Year Financial Statements	PRICE SENSITIVE	27/02/25	676.88KB	Share
ILA	Application for quotation of securities - ILA		26/02/25	15.57KB	Share
ILA	Change in substantial holding		19/02/25	267.52KB	Share
ILA	Application for quotation of securities - ILA		19/02/25	15.56KB	Share
ILA	Notification regarding unquoted securities - ILA		13/02/25	16.74KB	Share
ILA	Change of Director's Interest Notice (PL)		13/02/25	195.87KB	Share
ILA	Completion of patient dosing in Phase 2b clinical trial	PRICE SENSITIVE	12/02/25	444.74KB	Share
ILA	Application for quotation of securities - ILA		12/02/25	15.55KB	Share
ILA	ILAO option expiry reminder and exercise instructions		06/02/25	131.22KB	Share
ILA	Application for quotation of securities - ILA		05/02/25	15.55KB	Share
ILA	Final Director's Interest Notice - AH		03/02/25	249.42KB	Share
ILA	Quarterly Activities & Cashflow Report	PRICE SENSITIVE	30/01/25	392.44KB	Share
ILA	Application for quotation of securities - ILA		29/01/25	15.55KB	Share
ILA	Results of EGM		28/01/25	22.79KB	Share
ILA	Completion of enrolment in Phase 2b arm	PRICE SENSITIVE	22/01/25	136.01KB	Share
ILA	Application for quotation of securities - ILA		22/01/25	15.55KB	Share
ILA	Application for quotation of securities - ILA		15/01/25	15.55KB	Share
ILA	ISLA-101 Phase 2b clinical trial enrols first subjects	PRICE SENSITIVE	08/01/25	602.87KB	Share
ILA	Application for quotation of securities - ILA		24/12/24	15.55KB	Share
ILA	Letter to Shareholders, Notice of EGM & Proxy Form		20/12/24	336.24KB	Share
ILA	Application for quotation of securities - ILA		18/12/24	15.55KB	Share
ILA	Change of Director's Interest Notice x 2 (CN & DF)		17/12/24	264.02KB	Share
ILA	Notification regarding unquoted securities - ILA		17/12/24	16.88KB	Share
ILA	US patent granted for ISLA-101	PRICE SENSITIVE	11/12/24	128.07KB	Share
ILA	Change in substantial holding		10/12/24	296.16KB	Share
ILA	Change in substantial holding		05/12/24	133.43KB	Share
ILA	Change of Director's Interest Notice (CN)		05/12/24	298.46KB	Share
ILA	Change in substantial holding		04/12/24	94.87KB	Share
ILA	Application for quotation of securities - ILA		04/12/24	15.51KB	Share
ILA	Cleansing Notice		04/12/24	457.72KB	Share
ILA	Notification regarding unquoted securities - ILA		04/12/24	23.01KB	Share

ILA FDA Meeting request granted
19/09/25	PRICE SENSITIVE	126KB	Share
ILA Investor webinar
18/09/25		122.36KB	Share
ILA Investor presentation - Galidesivir update
17/09/25		1.61MB	Share
ILA Cleansing Notice
09/09/25		192.13KB	Share
ILA Application for quotation of securities - ILA
09/09/25		15.54KB	Share
ILA Letter to Shareholders, Notice of AGM & Proxy Form
05/09/25		515.45KB	Share
ILA FDA meeting request lodged for Galidesivir
01/09/25	PRICE SENSITIVE	138.45KB	Share
ILA Annual Report to shareholders (incl auditor independence)
29/08/25		1.96MB	Share
ILA Appendix 4G and Corporate Governance Statement
29/08/25		555.52KB	Share
ILA Annual Report to shareholders
29/08/25		1.89MB	Share
ILA Preliminary Final Report
29/08/25	PRICE SENSITIVE	219.79KB	Share
ILA Change in substantial holding
15/08/25		125.66KB	Share
ILA Date of AGM & Closing Date for Director Nominations
14/08/25		269.6KB	Share
ILA Presentation to the Third Annual Dengue Endgame Summit
14/08/25		910.2KB	Share
ILA Options exercise from existing substantial shareholder
11/08/25	PRICE SENSITIVE	132KB	Share
ILA Cleansing Notice
11/08/25		215.07KB	Share
ILA Application for quotation of securities - ILA
11/08/25		15.64KB	Share
ILA Completion of Galidesivir transaction
31/07/25	PRICE SENSITIVE	139.13KB	Share
ILA Investor Presentation and investor roadshow
28/07/25		1.54MB	Share
ILA Change of Director's Interest Notice - JC
25/07/25		4.22KB	Share
ILA Quarterly Appendix 4C and Activities Report
24/07/25	PRICE SENSITIVE	322.82KB	Share
ILA Change in substantial holding
17/07/25		916.52KB	Share
ILA Options exercise from existing substantial shareholder
17/07/25	PRICE SENSITIVE	203.8KB	Share
ILA Cleansing Notice
16/07/25		127.73KB	Share
ILA Application for quotation of securities - ILA
16/07/25		18.19KB	Share
ILA Investor presentation
09/07/25		836.38KB	Share
ILA Portfolio expansion achieved with acquisition of Galidesivir
09/07/25	PRICE SENSITIVE	176.75KB	Share
ILA Trading Halt
07/07/25	PRICE SENSITIVE	327.78KB	Share
ILA Notification of cessation of securities - ILA
04/07/25		13KB	Share
ILA Cancel - Notification of cessation of securities - ILA
04/07/25		12.63KB	Share
ILA Initial Director's Interest Notice
03/07/25		237.76KB	Share
ILA Notification of cessation of securities - ILA
03/07/25		12.95KB	Share
ILA Final Director's Interest Notice
03/07/25		268.22KB	Share
ILA Appointment of Jason Carroll as Non-Executive Chairman
02/07/25		137.5KB	Share
ILA Webinar presentation
17/06/25		1.53MB	Share
ILA Successful Phase 2 clinical trial of ISLA-101
12/06/25	PRICE SENSITIVE	185.05KB	Share
ILA Trading Halt
10/06/25	PRICE SENSITIVE	291.09KB	Share
ILA Cleansing Notice
04/06/25		230.14KB	Share
ILA Application for quotation of securities - ILA
04/06/25		15.66KB	Share
ILA Change in substantial holding
03/06/25		853.1KB	Share
ILA Change in substantial holding
02/06/25		270.65KB	Share
ILA Change in substantial holding
29/05/25		264.18KB	Share
ILA Cleansing Notice
29/05/25		133.9KB	Share
ILA Application for quotation of securities - ILA
29/05/25		15.67KB	Share
ILA Proposed issue of securities - ILA
21/05/25		14.86KB	Share
ILA Proposed issue of securities - ILA
21/05/25		15.72KB	Share
ILA Proposed issue of securities - ILA
21/05/25		15.59KB	Share
ILA Island completes $3.6 million placement
21/05/25	PRICE SENSITIVE	152.6KB	Share
ILA Trading Halt
19/05/25	PRICE SENSITIVE	342.25KB	Share
ILA Investor Presentation
08/05/25		1.55MB	Share
ILA Quarterly Activities & Cashflow Report
30/04/25	PRICE SENSITIVE	293.98KB	Share
ILA Phase 2a/b clinical trial update
23/04/25	PRICE SENSITIVE	147.37KB	Share
ILA Notification of cessation of securities - ILA
14/04/25		12.83KB	Share
ILA Change in substantial holding
26/03/25		154.55KB	Share
ILA Ceasing to be a substantial holder
25/03/25		122.32KB	Share
ILA Change in substantial holding
25/03/25		265.65KB	Share
ILA Change in substantial holding
24/03/25		267.14KB	Share
ILA Spark Plus Healthcare Conference Investor Presentation
24/03/25		1.47MB	Share
ILA Change in substantial holding
21/03/25		820KB	Share
ILA Total of $2.72m raised from ILAO options
19/03/25		148.5KB	Share
ILA Notification of cessation of securities - ILA
19/03/25		223.09KB	Share
ILA Change of Director's Interest Notice - PL
19/03/25		139.75KB	Share
ILA Application for quotation of securities - ILA
19/03/25		337KB	Share
ILA Application for quotation of securities - ILA
12/03/25		336.88KB	Share
ILA Change of Director's Interest Notice - DF
05/03/25		145.29KB	Share
ILA Application for quotation of securities - ILA
05/03/25		15.57KB	Share
ILA Cleansing Notice
05/03/25		130.25KB	Share
ILA Application for quotation of securities - ILA
05/03/25		16.44KB	Share
ILA Application for quotation of securities - ILA
05/03/25		16.45KB	Share
ILA Appendix 4D & Half-Year Financial Statements
27/02/25	PRICE SENSITIVE	676.88KB	Share
ILA Application for quotation of securities - ILA
26/02/25		15.57KB	Share
ILA Change in substantial holding
19/02/25		267.52KB	Share
ILA Application for quotation of securities - ILA
19/02/25		15.56KB	Share
ILA Notification regarding unquoted securities - ILA
13/02/25		16.74KB	Share
ILA Change of Director's Interest Notice (PL)
13/02/25		195.87KB	Share
ILA Completion of patient dosing in Phase 2b clinical trial
12/02/25	PRICE SENSITIVE	444.74KB	Share
ILA Application for quotation of securities - ILA
12/02/25		15.55KB	Share
ILA ILAO option expiry reminder and exercise instructions
06/02/25		131.22KB	Share
ILA Application for quotation of securities - ILA
05/02/25		15.55KB	Share
ILA Final Director's Interest Notice - AH
03/02/25		249.42KB	Share
ILA Quarterly Activities & Cashflow Report
30/01/25	PRICE SENSITIVE	392.44KB	Share
ILA Application for quotation of securities - ILA
29/01/25		15.55KB	Share
ILA Results of EGM
28/01/25		22.79KB	Share
ILA Completion of enrolment in Phase 2b arm
22/01/25	PRICE SENSITIVE	136.01KB	Share
ILA Application for quotation of securities - ILA
22/01/25		15.55KB	Share
ILA Application for quotation of securities - ILA
15/01/25		15.55KB	Share
ILA ISLA-101 Phase 2b clinical trial enrols first subjects
08/01/25	PRICE SENSITIVE	602.87KB	Share
ILA Application for quotation of securities - ILA
24/12/24		15.55KB	Share
ILA Letter to Shareholders, Notice of EGM & Proxy Form
20/12/24		336.24KB	Share
ILA Application for quotation of securities - ILA
18/12/24		15.55KB	Share
ILA Change of Director's Interest Notice x 2 (CN & DF)
17/12/24		264.02KB	Share
ILA Notification regarding unquoted securities - ILA
17/12/24		16.88KB	Share
ILA US patent granted for ISLA-101
11/12/24	PRICE SENSITIVE	128.07KB	Share
ILA Change in substantial holding
10/12/24		296.16KB	Share
ILA Change in substantial holding
05/12/24		133.43KB	Share
ILA Change of Director's Interest Notice (CN)
05/12/24		298.46KB	Share
ILA Change in substantial holding
04/12/24		94.87KB	Share
ILA Application for quotation of securities - ILA
04/12/24		15.51KB	Share
ILA Cleansing Notice
04/12/24		457.72KB	Share
ILA Notification regarding unquoted securities - ILA
04/12/24		23.01KB	Share

REFRESH

1 2 3 4

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 43.5¢		Change 0.070(19.2%)		Mkt cap ! $110.3M

Open	High	Low	Value	Volume
36.5¢	46.0¢	35.5¢	$1.221M	2.977M

Buyers (Bids)

No.	Vol.	Price($)
2	3939	43.5¢

Sellers (Offers)

Price($)	Vol.	No.
45.0¢	12200	2

View Market Depth

No.	Vol.	Price($)
1	1000	0.435
1	4719	0.430
2	9648	0.420
3	16267	0.400
1	2000	0.395

Price($)	Vol.	No.
0.450	3700	1
0.460	34750	1
0.470	1550	1
0.500	4000	1
0.510	59000	1

Last trade - 16.10pm 19/09/2025 (20 minute delay)

ILA (ASX) Chart

ISLAND PHARMACEUTICALS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories